Endocrine-Related Cancer

References

1. ↵
   1. Abbott AL,
   2. Alvarez-Saavedra E,
   3. Miska EA,
   4. Lau NC,
   5. Bartel DP,
   6. Horvitz HR &
   7. Ambros V

   2005 The let-7 microRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Developmental Cell 9 403– 414.
2. ↵
   1. Akao Y,
   2. Nakagawa Y,
   3. Iio A &
   4. Naoe T

   2009 Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leukemia Research 33 1530– 1538.
3. ↵
   1. Alvarez-Garcia I &
   2. Miska EA

   2005 MicroRNA functions in animal development and human disease. Development 132 4653– 4662.
4. ↵
   1. Bashirullah A,
   2. Pasquinelli AE,
   3. Kiger AA,
   4. Perrimon N,
   5. Ruvkun G &
   6. Thummel CS

   2003 Coordinate regulation of small temporal RNAs at the onset of Drosophila metamorphosis. Developmental Biology 259 1– 8.
5. ↵
   1. Bethke A,
   2. Fielenbach N,
   3. Wang Z,
   4. Mangelsdorf DJ &
   5. Antebi A

   2009 Nuclear hormone receptor regulation of microRNAs controls developmental progression. Science 324 95– 98.
6. ↵
   1. Blower PE,
   2. Chung JH,
   3. Verducci JS,
   4. Lin S,
   5. Park JK,
   6. Dai Z,
   7. Liu CG,
   8. Schmittgen TD,
   9. Reinhold WC,
   10. Croce CM
   11. et al.

   2008 MicroRNAs modulate the chemosensitivity of tumor cells. Molecular Cancer Therapeutics 7 1– 9.
7. ↵
   1. Boren T,
   2. Xiong Y,
   3. Hakam A,
   4. Wenham R,
   5. Apte S,
   6. Chan G,
   7. Kamath SG,
   8. Chen DT,
   9. Dressman H &
   10. Lancaster JM

   2009 MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecologic Oncology 113 249– 255.
8. ↵
   1. Boyerinas B,
   2. Park SM,
   3. Shomron N,
   4. Hedegaard MM,
   5. Vinther J,
   6. Andersen JS,
   7. Feig C,
   8. Xu J,
   9. Burge CB &
   10. Peter ME

   2008 Identification of let-7-regulated oncofetal genes. Cancer Research 68 2587– 2591.
9. ↵
   1. Brueckner B,
   2. Stresemann C,
   3. Kuner R,
   4. Mund C,
   5. Musch T,
   6. Meister M,
   7. Sultmann H &
   8. Lyko F

   2007 The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Research 67 1419– 1423.
10. ↵
    1. Bussing I,
    2. Slack FJ &
    3. Grosshans H

    2008 Let-7 microRNAs in development, stem cells and cancer. Trends in Molecular Medicine 14 400– 409.
11. ↵
    1. Caygill EE &
    2. Johnston LA

    2008 Temporal regulation of metamorphic processes in Drosophila by the let-7 and miR-125 heterochronic microRNAs. Current Biology 18 943– 950.
12. ↵
    1. Chang TC,
    2. Wentzel EA,
    3. Kent OA,
    4. Ramachandran K,
    5. Mullendore M,
    6. Lee KH,
    7. Feldmann G,
    8. Yamakuchi M,
    9. Ferlito M,
    10. Lowenstein CJ
    11. et al.

    2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 26 745– 752.
13. ↵
    1. Chang SS,
    2. Jiang WW,
    3. Smith I,
    4. Poeta LM,
    5. Begum S,
    6. Glazer C,
    7. Shan S,
    8. Westra W,
    9. Sidransky D &
    10. Califano JA

    2008a MicroRNA alterations in head and neck squamous cell carcinoma. International Journal of Cancer 123 2791– 2797.
14. ↵
    1. Chang TC,
    2. Yu D,
    3. Lee YS,
    4. Wentzel EA,
    5. Arking DE,
    6. West KM,
    7. Dang CV,
    8. Thomas-Tikhonenko A &
    9. Mendell JT

    2008b Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genetics 40 43– 50.
15. ↵
    1. Chang TC,
    2. Zeitels LR,
    3. Hwang HW,
    4. Chivukula RR,
    5. Wentzel EA,
    6. Dews M,
    7. Jung J,
    8. Gao P,
    9. Dang CV,
    10. Beer MA
    11. et al.

    2009 Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. PNAS 106 3384– 3389.
16. ↵
    1. Chaudhry MA

    2009 Real-time PCR analysis of micro-RNA expression in ionizing radiation-treated cells. Cancer Biotherapy & Radio Pharmaceuticals 24 49– 56.
17. ↵
    1. Chen GQ,
    2. Zhao ZW,
    3. Zhou HY,
    4. Liu YJ &
    5. Yang HJ

    2009 Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin. Medical Oncology[in press].
18. ↵
    1. Childs G,
    2. Fazzari M,
    3. Kung G,
    4. Kawachi N,
    5. Brandwein-Gensler M,
    6. McLemore M,
    7. Chen Q,
    8. Burk RD,
    9. Smith RV,
    10. Prystowsky MB
    11. et al.

    2009 Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. American Journal of Pathology 174 736– 745.
19. ↵
    1. Chin LJ,
    2. Ratner E,
    3. Leng S,
    4. Zhai R,
    5. Nallur S,
    6. Babar I,
    7. Muller RU,
    8. Straka E,
    9. Su L,
    10. Burki EA
    11. et al.

    2008 A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Research 68 8535– 8540.
20. ↵
    1. Christensen BC,
    2. Moyer BJ,
    3. Avissar M,
    4. Ouellet LG,
    5. Plaza SL,
    6. McClean MD,
    7. Marsit CJ &
    8. Kelsey KT

    2009 A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 30 1003– 1007.
21. ↵
    1. Cochrane DR,
    2. Spoelstra NS,
    3. Howe EN,
    4. Nordeen SK &
    5. Richer JK

    2009 MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Molecular Cancer Therapeutics[in press].
22. ↵
    1. Cullen BR

    2004 Transcription and processing of human microRNA precursors. Molecular Cell 16 861– 865.
23. ↵
    1. Dahiya N,
    2. Sherman-Baust CA,
    3. Wang TL,
    4. Davidson B,
    5. Shih Ie M,
    6. Zhang Y,
    7. Wood W III.,
    8. Becker KG &
    9. Morin PJ

    2008 MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3 e2436.
24. ↵
    1. Dangi-Garimella S,
    2. Yun J,
    3. Eves EM,
    4. Newman M,
    5. Erkeland SJ,
    6. Hammond SM,
    7. Minn AJ &
    8. Rosner MR

    2009 Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO Journal 28 347– 358.
25. ↵
    1. Ding XC,
    2. Slack FJ &
    3. Grosshans H

    2008 The let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiation. Cell Cycle 7 3083– 3090.
26. ↵
    1. Esquela-Kerscher A,
    2. Johnson SM,
    3. Bai L,
    4. Saito K,
    5. Partridge J,
    6. Reinert KL &
    7. Slack FJ

    2005 Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system. Developmental Dynamics 234 868– 877.
27. ↵
    1. Esquela-Kerscher A,
    2. Trang P,
    3. Wiggins JF,
    4. Patrawala L,
    5. Cheng A,
    6. Ford L,
    7. Weidhaas JB,
    8. Brown D,
    9. Bader AG &
    10. Slack FJ

    2008 The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7 759– 764.
28. ↵
    1. Forman JJ,
    2. Legesse-Miller A &
    3. Coller HA

    2008 A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. PNAS 105 14879– 14884.
29. ↵
    1. Garofalo M,
    2. Quintavalle C,
    3. Di Leva G,
    4. Zanca C,
    5. Romano G,
    6. Taccioli C,
    7. Liu CG,
    8. Croce CM &
    9. Condorelli G

    2008 MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27 3845– 3855.
30. ↵
    1. Grosshans H,
    2. Johnson T,
    3. Reinert KL,
    4. Gerstein M &
    5. Slack FJ

    2005 The temporal patterning microRNA let-7 regulates several transcription factors at the larval to adult transition in C. elegans. Developmental Cell 8 321– 330.
31. ↵
    1. Gu J &
    2. Iyer VR

    2006 PI3K signaling and miRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli. Genome Biology 7 R42.
32. ↵
    1. Guled M,
    2. Lahti L,
    3. Lindholm PM,
    4. Salmenkivi K,
    5. Bagwan I,
    6. Nicholson AG &
    7. Knuutila S

    2009 CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma – A miRNA microarray analysis. Genes, Chromosomes & Cancer 48 615– 623.
33. ↵
    1. Guo Y,
    2. Chen Y,
    3. Ito H,
    4. Watanabe A,
    5. Ge X,
    6. Kodama T &
    7. Aburatani H

    2006 Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384 51– 61.
34. ↵
    1. Hagan JP,
    2. Piskounova E &
    3. Gregory RI

    2009 Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nature Structural & Molecular Biology 16 1021– 1025.
35. ↵
    1. Hayes GD &
    2. Ruvkun G

    2006 Misexpression of the Caenorhabditis elegans miRNA let-7 is sufficient to drive developmental programs. Cold Spring Harbor Symposia on Quantitative Biology 71 21– 27.
36. ↵
    1. Heo I,
    2. Joo C,
    3. Cho J,
    4. Ha M,
    5. Han J &
    6. Kim VN

    2008 Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Molecular Cell 32 276– 284.
37. ↵
    1. Heo I,
    2. Joo C,
    3. Kim YK,
    4. Ha M,
    5. Yoon MJ,
    6. Cho J,
    7. Yeom KH,
    8. Han J &
    9. Kim VN

    2009 TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138 696– 708.
38. ↵
    1. Huang JC,
    2. Babak T,
    3. Corson TW,
    4. Chua G,
    5. Khan S,
    6. Gallie BL,
    7. Hughes TR,
    8. Blencowe BJ,
    9. Frey BJ &
    10. Morris QD

    2007 Using expression profiling data to identify human microRNA targets. Nature Methods 4 1045– 1049.
39. ↵
    1. Hutvagner G,
    2. McLachlan J,
    3. Pasquinelli AE,
    4. Balint E,
    5. Tuschl T &
    6. Zamore PD

    2001 A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 834– 838.
40. ↵
    1. Ibarra I,
    2. Erlich Y,
    3. Muthuswamy SK,
    4. Sachidanandam R &
    5. Hannon GJ

    2007 A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes and Development 21 3238– 3243.
41. ↵
    1. Iliopoulos D,
    2. Bimpaki EI,
    3. Nesterova M &
    4. Stratakis CA

    2009 MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. Cancer Research 69 3278– 3282.
42. ↵
    1. Iorio MV,
    2. Casalini P,
    3. Piovan C,
    4. Di Leva G,
    5. Merlo A,
    6. Triulzi T,
    7. Menard S,
    8. Croce CM &
    9. Tagliabue E

    2009 MicroRNA-205 regulates HER3 in human breast cancer. Cancer Research 69 2195– 2200.
43. ↵
    1. Johnson SM,
    2. Grosshans H,
    3. Shingara J,
    4. Byrom M,
    5. Jarvis R,
    6. Cheng A,
    7. Labourier E,
    8. Reinert KL,
    9. Brown D &
    10. Slack FJ

    2005 RAS is regulated by the let-7 microRNA family. Cell 120 635– 647.
44. ↵
    1. Johnson CD,
    2. Esquela-Kerscher A,
    3. Stefani G,
    4. Byrom M,
    5. Kelnar K,
    6. Ovcharenko D,
    7. Wilson M,
    8. Wang X,
    9. Shelton J,
    10. Shingara J
    11. et al.

    2007 The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Research 67 7713– 7722.
45. ↵
    1. Josson S,
    2. Sung SY,
    3. Lao K,
    4. Chung LW &
    5. Johnstone PA

    2008 Radiation modulation of microRNA in prostate cancer cell lines. Prostate 68 1599– 1606.
46. ↵
    1. Jovanovic M &
    2. Hengartner MO

    2006 miRNAs and apoptosis: RNAs to die for. Oncogene 25 6176– 6187.
47. ↵
    1. Kent OA &
    2. Mendell JT

    2006 A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25 6188– 6196.
48. ↵
    1. Ketting RF,
    2. Fischer SE,
    3. Bernstein E,
    4. Sijen T,
    5. Hannon GJ &
    6. Plasterk RH

    2001 Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes and Development 15 2654– 2659.
49. ↵
    1. Kim HH,
    2. Kuwano Y,
    3. Srikantan S,
    4. Lee EK,
    5. Martindale JL &
    6. Gorospe M

    2009 HuR recruits let-7/RISC to repress c-Myc expression. Genes and Development 23 1743– 1748.
50. ↵
    1. Kloosterman WP,
    2. Wienholds E,
    3. Ketting RF &
    4. Plasterk RH

    2004 Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Research 32 6284– 6291.
51. ↵
    1. Kovalchuk O,
    2. Filkowski J,
    3. Meservy J,
    4. Ilnytskyy Y,
    5. Tryndyak VP,
    6. Chekhun VF &
    7. Pogribny IP

    2008 Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Molecular Cancer Therapeutics 7 2152– 2159.
52. ↵
    1. Kumar MS,
    2. Erkeland SJ,
    3. Pester RE,
    4. Chen CY,
    5. Ebert MS,
    6. Sharp PA &
    7. Jacks T

    2008 Suppression of non-small cell lung tumor development by the let-7 microRNA family. PNAS 105 3903– 3908.
53. ↵
    1. Lagos-Quintana M,
    2. Rauhut R,
    3. Lendeckel W &
    4. Tuschl T

    2001 Identification of novel genes coding for small expressed RNAs. Science 294 853– 858.
54. ↵
    1. Lai EC

    2002 Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nature Genetics 30 363– 364.
55. ↵
    1. Lal A,
    2. Pan Y,
    3. Navarro F,
    4. Dykxhoorn DM,
    5. Moreau L,
    6. Meire E,
    7. Bentwich Z,
    8. Lieberman J &
    9. Chowdhury D

    2009 miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nature Structural & Molecular Biology 16 492– 498.
56. ↵
    1. Lancman JJ,
    2. Caruccio NC,
    3. Harfe BD,
    4. Pasquinelli AE,
    5. Schageman JJ,
    6. Pertsemlidis A &
    7. Fallon JF

    2005 Analysis of the regulation of lin-41 during chick and mouse limb development. Developmental Dynamics 234 948– 960.
57. ↵
    1. Lau NC,
    2. Lim LP,
    3. Weinstein EG &
    4. Bartel DP

    2001 An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 858– 862.
58. ↵
    1. Lawrie CH,
    2. Chi J,
    3. Taylor S,
    4. Tramonti D,
    5. Ballabio E,
    6. Palazzo S,
    7. Saunders NJ,
    8. Pezzella F,
    9. Boultwood J,
    10. Wainscoat JS
    11. et al.

    2008 Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival, and transformation from follicular lymphoma. Journal of Cellular and Molecular Medicine 13 1248– 1260.
59. ↵
    1. Lee RC &
    2. Ambros V

    2001 An extensive class of small RNAs in Caenorhabditis elegans. Science 294 862– 864.
60. ↵
    1. Lee YS &
    2. Dutta A

    2007 The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes and Development 21 1025– 1030.
61. ↵
    1. Lee RC,
    2. Feinbaum RL &
    3. Ambros V

    1993 The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 843– 854.
62. ↵
    1. Lee Y,
    2. Ahn C,
    3. Han J,
    4. Choi H,
    5. Kim J,
    6. Yim J,
    7. Lee J,
    8. Provost P,
    9. Radmark O,
    10. Kim S
    11. et al.

    2003 The nuclear RNase III Drosha initiates microRNA processing. Nature 425 415– 419.
63. ↵
    1. Legesse-Miller A,
    2. Elemento O,
    3. Pfau SJ,
    4. Forman JJ,
    5. Tavazoie S &
    6. Coller HA

    2009 let-7 Overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in primary fibroblasts. Journal of Biological Chemistry 284 6605– 6609.
64. ↵
    1. Lehrbach NJ,
    2. Armisen J,
    3. Lightfoot HL,
    4. Murfitt KJ,
    5. Bugaut A,
    6. Balasubramanian S &
    7. Miska EA

    2009 LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nature Structural & Molecular Biology 16 1016– 1020.
65. ↵
    1. Lettre G,
    2. Jackson AU,
    3. Gieger C,
    4. Schumacher FR,
    5. Berndt SI,
    6. Sanna S,
    7. Eyheramendy S,
    8. Voight BF,
    9. Butler JL,
    10. Guiducci C
    11. et al.

    2008 Identification of ten loci associated with height highlights new biological pathways in human growth. Nature Genetics 40 584– 591.
66. ↵
    1. Leucci E,
    2. Cocco M,
    3. Onnis A,
    4. De Falco G,
    5. van Cleef P,
    6. Bellan C,
    7. van Rijk A,
    8. Nyagol J,
    9. Byakika B,
    10. Lazzi S
    11. et al.

    2008 MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. Journal of Pathology 216 440– 450.
67. ↵
    1. Li M,
    2. Jones-Rhoades MW,
    3. Lau NC,
    4. Bartel DP &
    5. Rougvie AE

    2005 Regulatory mutations of mir-48, a C. elegans let-7 family microRNA, cause developmental timing defects. Developmental Cell 9 415– 422.
68. ↵
    1. Lin YC,
    2. Hsieh LC,
    3. Kuo MW,
    4. Yu J,
    5. Kuo HH,
    6. Lo WL,
    7. Lin RJ,
    8. Yu AL &
    9. Li WH

    2007 Human TRIM71 and its nematode homologue are targets of let-7 microRNA and its zebrafish orthologue is essential for development. Molecular Biology and Evolution 24 2525– 2534.
69. ↵
    1. Liu S,
    2. Xia Q,
    3. Zhao P,
    4. Cheng T,
    5. Hong K &
    6. Xiang Z

    2007 Characterization and expression patterns of let-7 microRNA in the silkworm (Bombyx mori). BMC Developmental Biology 7 88.
70. ↵
    1. Lu J,
    2. Getz G,
    3. Miska EA,
    4. Alvarez-Saavedra E,
    5. Lamb J,
    6. Peck D,
    7. Sweet-Cordero A,
    8. Ebert BL,
    9. Mak RH,
    10. Ferrando AA
    11. et al.

    2005 MicroRNA expression profiles classify human cancers. Nature 435 834– 838.
71. ↵
    1. Lu L,
    2. Katsaros D,
    3. de la Longrais IA,
    4. Sochirca O &
    5. Yu H

    2007 Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Research 67 10117– 10122.
72. ↵
    1. Lu L,
    2. Katsaros D,
    3. Shaverdashvili K,
    4. Qian B,
    5. Wu Y,
    6. de la Longrais IA,
    7. Preti M,
    8. Menato G &
    9. Yu H

    2009 Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. European Journal of Cancer 45 2212– 2218.
73. ↵
    1. Maes OC,
    2. Sarojini H &
    3. Wang E

    2009 Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. Journal of Cellular Physiology 221 109– 119.
74. ↵
    1. Mathonnet G,
    2. Fabian MR,
    3. Svitkin YV,
    4. Parsyan A,
    5. Huck L,
    6. Murata T,
    7. Biffo S,
    8. Merrick WC,
    9. Darzynkiewicz E,
    10. Pillai RS
    11. et al.

    2007 MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317 1764– 1767.
75. ↵
    1. Mayr C,
    2. Hemann MT &
    3. Bartel DP

    2007 Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 1576– 1579.
76. ↵
    1. Meng F,
    2. Henson R,
    3. Lang M,
    4. Wehbe H,
    5. Maheshwari S,
    6. Mendell JT,
    7. Jiang J,
    8. Schmittgen TD &
    9. Patel T

    2006 Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130 2113– 2129.
77. ↵
    1. Mi S,
    2. Lu J,
    3. Sun M,
    4. Li Z,
    5. Zhang H,
    6. Neilly MB,
    7. Wang Y,
    8. Qian Z,
    9. Jin J,
    10. Zhang Y
    11. et al.

    2007 MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. PNAS 104 19971– 19976.
78. ↵
    1. Mishra PJ,
    2. Humeniuk R,
    3. Longo-Sorbello GS,
    4. Banerjee D &
    5. Bertino JR

    2007 A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. PNAS 104 13513– 13518.
79. ↵
    1. Muller DW &
    2. Bosserhoff AK

    2008 Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 27 6698– 6706.
80. ↵
    1. Nam EJ,
    2. Yoon H,
    3. Kim SW,
    4. Kim H,
    5. Kim YT,
    6. Kim JH,
    7. Kim JW &
    8. Kim S

    2008 MicroRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 14 2690– 2695.
81. ↵
    1. Narita M,
    2. Krizhanovsky V,
    3. Nunez S,
    4. Chicas A,
    5. Hearn SA,
    6. Myers MP &
    7. Lowe SW

    2006 A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126 503– 514.
82. ↵
    1. Nasser MW,
    2. Datta J,
    3. Nuovo G,
    4. Kutay H,
    5. Motiwala T,
    6. Majumder S,
    7. Wang B,
    8. Suster S,
    9. Jacob ST &
    10. Ghoshal K

    2008 Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. Journal of Biological Chemistry 283 33394– 33405.
83. ↵
    1. Newman MA,
    2. Thomson JM &
    3. Hammond S

    2008 Lin-28 interaction with the let-7 precursor loop mediates regulated microRNA processing. RNA 14 1539– 1549.
84. ↵
    1. Nie K,
    2. Gomez M,
    3. Landgraf P,
    4. Garcia JF,
    5. Liu Y,
    6. Tan LH,
    7. Chadburn A,
    8. Tuschl T,
    9. Knowles DM &
    10. Tam W

    2008 MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. American Journal of Pathology 173 242– 252.
85. ↵
    1. Nishino J,
    2. Kim I,
    3. Chada K &
    4. Morrison SJ

    2008 Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 135 227– 239.
86. ↵
    1. O'Farrell F,
    2. Esfahani SS,
    3. Engstrom Y &
    4. Kylsten P

    2008 Regulation of the Drosophila lin-41 homologue dappled by let-7 reveals conservation of a regulatory mechanism within the LIN-41 subclade. Developmental Dynamics 237 196– 208.
87. ↵
    1. O'Hara AJ,
    2. Wang L,
    3. Dezube BJ,
    4. Harrington WJ Jr.,
    5. Damania B &
    6. Dittmer DP

    2009 Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood 113 5938– 5941.
88. ↵
    1. Ozen M,
    2. Creighton CJ,
    3. Ozdemir M &
    4. Ittmann M

    2008 Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27 1788– 1793.
89. ↵
    1. Pan YZ,
    2. Morris ME &
    3. Yu AM

    2009 MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Molecular Pharmacology 75 1374– 1379.
90. ↵
    1. Park SM,
    2. Shell S,
    3. Radjabi AR,
    4. Schickel R,
    5. Feig C,
    6. Boyerinas B,
    7. Dinulescu DM,
    8. Lengyel E &
    9. Peter ME

    2007 Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6 2585– 2590.
91. ↵
    1. Pasquinelli AE,
    2. Reinhart BJ,
    3. Slack F,
    4. Martindale MQ,
    5. Kuroda MI,
    6. Maller B,
    7. Hayward DC,
    8. Ball EE,
    9. Degnan B,
    10. Muller P
    11. et al.

    2000 Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 86– 89.
92. ↵
    1. Peng Y,
    2. Laser J,
    3. Shi G,
    4. Mittal K,
    5. Melamed J,
    6. Lee P &
    7. Wei JJ

    2008 Antiproliferative effects by let-7 repression of high-mobility group A2 in uterine leiomyoma. Molecular Cancer Research 6 663– 673.
93. ↵
    1. Peter ME

    2009 Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8 843– 852.
94. ↵
    1. Piskounova E,
    2. Viswanathan SR,
    3. Janas M,
    4. Lapierre RJ,
    5. Daley GQ,
    6. Sliz P &
    7. Gregory RI

    2008 Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. Journal of Biological Chemistry 283 21310– 21314.
95. ↵
    1. Qian ZR,
    2. Asa SL,
    3. Siomi H,
    4. Siomi MC,
    5. Yoshimoto K,
    6. Yamada S,
    7. Wang EL,
    8. Rahman MM,
    9. Inoue H,
    10. Itakura M
    11. et al.

    2009 Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Modern Pathology 22 431– 441.
96. ↵
    1. Reinhart BJ,
    2. Slack FJ,
    3. Basson M,
    4. Pasquinelli AE,
    5. Bettinger JC,
    6. Rougvie AE,
    7. Horvitz HR &
    8. Ruvkun G

    2000 The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 901– 906.
97. ↵
    1. Roush S &
    2. Slack FJ

    2008 The let-7 family of microRNAs. Trends in Cell Biology 18 505– 516.
98. ↵
    1. Ruby JG,
    2. Jan C,
    3. Player C,
    4. Axtell MJ,
    5. Lee W,
    6. Nusbaum C,
    7. Ge H &
    8. Bartel DP

    2006 Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 127 1193– 1207.
99. ↵
    1. Rybak A,
    2. Fuchs H,
    3. Smirnova L,
    4. Brandt C,
    5. Pohl EE,
    6. Nitsch R &
    7. Wulczyn FG

    2008 A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nature Cell Biology 10 987– 993.
100. ↵
     1. Sakamoto S,
     2. Aoki K,
     3. Higuchi T,
     4. Todaka H,
     5. Morisawa K,
     6. Tamaki N,
     7. Hatano E,
     8. Fukushima A,
     9. Taniguchi T &
     10. Agata Y

     2009 The NF90–NF45 complex functions as a negative regulator in the microRNA processing pathway. Molecular and Cellular Biology 29 3754– 3769.
101. ↵
     1. Sampson VB,
     2. Rong NH,
     3. Han J,
     4. Yang Q,
     5. Aris V,
     6. Soteropoulos P,
     7. Petrelli NJ,
     8. Dunn SP &
     9. Krueger LJ

     2007 MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Research 67 9762– 9770.
102. ↵
     1. Schickel R,
     2. Boyerinas B,
     3. Park SM &
     4. Peter ME

     2008 MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27 5959– 5974.
103. ↵
     1. Schulman BR,
     2. Esquela-Kerscher A &
     3. Slack FJ

     2005 Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Developmental Dynamics 234 1046– 1054.
104. ↵
     1. Schultz J,
     2. Lorenz P,
     3. Gross G,
     4. Ibrahim S &
     5. Kunz M

     2008 MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Research 18 549– 557.
105. ↵
     1. Sempere LF,
     2. Dubrovsky EB,
     3. Dubrovskaya VA,
     4. Berger EM &
     5. Ambros V

     2002 The expression of the let-7 small regulatory RNA is controlled by ecdysone during metamorphosis in Drosophila melanogaster. Developmental Biology 244 170– 179.
106. ↵
     1. Sempere LF,
     2. Freemantle S,
     3. Pitha-Rowe I,
     4. Moss E,
     5. Dmitrovsky E &
     6. Ambros V

     2004 Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biology 5 R13.
107. ↵
     1. Sempere LF,
     2. Christensen M,
     3. Silahtaroglu A,
     4. Bak M,
     5. Heath CV,
     6. Schwartz G,
     7. Wells W,
     8. Kauppinen S &
     9. Cole CN

     2007 Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Research 67 11612– 11620.
108. ↵
     1. Shell S,
     2. Park SM,
     3. Radjabi AR,
     4. Schickel R,
     5. Kistner EO,
     6. Jewell DA,
     7. Feig C,
     8. Lengyel E &
     9. Peter ME

     2007 Let-7 expression defines two differentiation stages of cancer. PNAS 104 11400– 11405.
109. ↵
     1. Sokol NS,
     2. Xu P,
     3. Jan YN &
     4. Ambros V

     2008 Drosophila let-7 microRNA is required for remodeling of the neuromusculature during metamorphosis. Genes and Development 22 1591– 1596.
110. ↵
     1. Sorrentino A,
     2. Liu CG,
     3. Addario A,
     4. Peschle C,
     5. Scambia G &
     6. Ferlini C

     2008 Role of microRNAs in drug-resistant ovarian cancer cells. Gynecologic Oncology 111 478– 486.
111. ↵
     1. Stefani G &
     2. Slack FJ

     2008 Small non-coding RNAs in animal development. Nature Review. Molecular and Cellular Biology 9 219– 230.
112. ↵
     1. Subramanian S,
     2. Lui WO,
     3. Lee CH,
     4. Espinosa I,
     5. Nielsen TO,
     6. Heinrich MC,
     7. Corless CL,
     8. Fire AZ &
     9. van de Rijn M

     2008 MicroRNA expression signature of human sarcomas. Oncogene 27 2015– 2026.
113. ↵
     1. Summer H,
     2. Li O,
     3. Bao Q,
     4. Zhan L,
     5. Peter S,
     6. Sathiyanathan P,
     7. Henderson D,
     8. Klonisch T,
     9. Goodman SD &
     10. Droge P

     2009 HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy. Nucleic Acids Research 37 4371– 4384.
114. ↵
     1. Sun T,
     2. Fu M,
     3. Bookout AL,
     4. Kliewer SA &
     5. Mangelsdorf DJ

     2009 MicroRNA let-7 regulates 3T3-L1 adipogenesis. Molecular Endocrinology 23 925– 931.
115. ↵
     1. Sureban SM,
     2. May R,
     3. Ramalingam S,
     4. Subramaniam D,
     5. Natarajan G,
     6. Anant S &
     7. Houchen CW

     2009 Selective blockade of DCAMKL-1 results in tumor growth arrest by a let-7a microRNA-dependent mechanism. Gastroenterology 137 649– 659.
116. ↵
     1. Takamizawa J,
     2. Konishi H,
     3. Yanagisawa K,
     4. Tomida S,
     5. Osada H,
     6. Endoh H,
     7. Harano T,
     8. Yatabe Y,
     9. Nagino M,
     10. Nimura Y
     11. et al.

     2004 Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Research 64 3753– 3756.
117. ↵
     1. Thomson JM,
     2. Parker J,
     3. Perou CM &
     4. Hammond SM

     2004 A custom microarray platform for analysis of microRNA gene expression. Nature Methods 1 47– 53.
118. ↵
     1. Thomson JM,
     2. Newman M,
     3. Parker JS,
     4. Morin-Kensicki EM,
     5. Wright T &
     6. Hammond SM

     2006 Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Development 20 2202– 2207.
119. ↵
     1. To KK,
     2. Zhan Z,
     3. Litman T &
     4. Bates SE

     2008 Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Molecular and Cellular Biology 28 5147– 5161.
120. ↵
     1. Tokumaru S,
     2. Suzuki M,
     3. Yamada H,
     4. Nagino M &
     5. Takahashi T

     2008 Let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 29 2073– 2077.
121. ↵
     1. Torrisani J,
     2. Bournet B,
     3. du Rieu MC,
     4. Bouisson M,
     5. Souque A,
     6. Escourrou J,
     7. Buscail L &
     8. Cordelier P

     2009 Let-7 microRNA rransfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Human Gene Therapy 20 831– 844.
122. ↵
     1. Tsang WP &
     2. Kwok TT

     2008 Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13 1215– 1222.
123. ↵
     1. Vasudevan S,
     2. Tong Y &
     3. Steitz JA

     2007 Switching from repression to activation: microRNAs can up-regulate translation. Science 318 1931– 1934.
124. ↵
     1. Viswanathan SR,
     2. Daley GQ &
     3. Gregory RI

     2008 Selective blockade of microRNA processing by lin-28. Science 320 97– 100.
125. ↵
     1. Viswanathan SR,
     2. Powers JT,
     3. Einhorn W,
     4. Hoshida Y,
     5. Ng TL,
     6. Toffanin S,
     7. O'Sullivan M,
     8. Lu J,
     9. Phillips LA,
     10. Lockhart VL
     11. et al.

     2009 Lin28 promotes transformation and is associated with advanced human malignancies. Nature Genetics 41 843– 848.
126. ↵
     1. Wagner W,
     2. Horn P,
     3. Castoldi M,
     4. Diehlmann A,
     5. Bork S,
     6. Saffrich R,
     7. Benes V,
     8. Blake J,
     9. Pfister S,
     10. Eckstein V
     11. et al.

     2008 Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 3 e2213.
127. ↵
     1. Watanabe S,
     2. Ueda Y,
     3. Akaboshi S,
     4. Hino Y,
     5. Sekita Y &
     6. Nakao M

     2009 HMGA2 maintains oncogenic RAS-induced epithelial–mesenchymal transition in human pancreatic cancer cells. American Journal of Pathology 174 854– 868.
128. ↵
     1. Weidhaas JB,
     2. Babar I,
     3. Nallur SM,
     4. Trang P,
     5. Roush S,
     6. Boehm M,
     7. Gillespie E &
     8. Slack FJ

     2007 MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Research 67 11111– 11116.
129. ↵
     1. West JA,
     2. Viswanathan SR,
     3. Yabuuchi A,
     4. Cunniff K,
     5. Takeuchi A,
     6. Park IH,
     7. Sero JE,
     8. Zhu H,
     9. Perez-Atayde A,
     10. Frazier AL
     11. et al.

     2009 A role for lin28 in primordial germ-cell development and germ-cell malignancy. Nature 460 909– 913.
130. ↵
     1. Wulczyn FG,
     2. Smirnova L,
     3. Rybak A,
     4. Brandt C,
     5. Kwidzinski E,
     6. Ninnemann O,
     7. Strehle M,
     8. Seiler A,
     9. Schumacher S &
     10. Nitsch R

     2007 Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB Journal 21 415– 426.
131. ↵
     1. Xia L,
     2. Zhang D,
     3. Pan Y,
     4. Zhao L,
     5. Sun S,
     6. Hong L,
     7. Liu J &
     8. Fan D

     2008 miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International Journal of Cancer 123 372– 379.
132. ↵
     1. Xin F,
     2. Li M,
     3. Balch C,
     4. Thomson M,
     5. Fan M,
     6. Liu Y,
     7. Hammond SM,
     8. Kim S &
     9. Nephew KP

     2009 Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics 25 430– 434.
133. ↵
     1. Xu B &
     2. Huang Y

     2009 Histone H2a mRNA interacts with Lin28 and contains a Lin28-dependent posttranscriptional regulatory element. Nucleic Acids Research 37 4256– 4263.
134. ↵
     1. Yan LX,
     2. Huang XF,
     3. Shao Q,
     4. Huang MY,
     5. Deng L,
     6. Wu QL,
     7. Zeng YX &
     8. Shao JY

     2008 MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14 2348– 2360.
135. ↵
     1. Yanaihara N,
     2. Caplen N,
     3. Bowman E,
     4. Seike M,
     5. Kumamoto K,
     6. Yi M,
     7. Stephens RM,
     8. Okamoto A,
     9. Yokota J,
     10. Tanaka T
     11. et al.

     2006 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 189– 198.
136. ↵
     1. Yang H,
     2. Kong W,
     3. He L,
     4. Zhao JJ,
     5. O'Donnell JD,
     6. Wang J,
     7. Wenham RM,
     8. Coppola D,
     9. Kruk PA,
     10. Nicosia SV
     11. et al.

     2008a MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 68 425– 433.
137. ↵
     1. Yang N,
     2. Kaur S,
     3. Volinia S,
     4. Greshock J,
     5. Lassus H,
     6. Hasegawa K,
     7. Liang S,
     8. Leminen A,
     9. Deng S,
     10. Smith L
     11. et al.

     2008b MicroRNA microarray identifies let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Research 68 10307– 10314.
138. ↵
     1. Yi R,
     2. Qin Y,
     3. Macara IG &
     4. Cullen BR

     2003 Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes and Development 17 3011– 3016.
139. ↵
     1. Yu F,
     2. Yao H,
     3. Zhu P,
     4. Zhang X,
     5. Pan Q,
     6. Gong C,
     7. Huang Y,
     8. Hu X,
     9. Su F,
     10. Lieberman J
     11. et al.

     2007a Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 1109– 1123.
140. ↵
     1. Yu J,
     2. Vodyanik MA,
     3. Smuga-Otto K,
     4. Antosiewicz-Bourget J,
     5. Frane JL,
     6. Tian S,
     7. Nie J,
     8. Jonsdottir GA,
     9. Ruotti V,
     10. Stewart R
     11. et al.

     2007b Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917– 1920.
141. ↵
     1. Zhou X,
     2. Benson KF,
     3. Ashar HR &
     4. Chada K

     1995 Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376 771– 774.
142. ↵
     1. Zhu H,
     2. Wu H,
     3. Liu X,
     4. Evans BR,
     5. Medina DJ,
     6. Liu CG &
     7. Yang JM

     2008 Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochemical Pharmacology 76 582– 588.